The table below shows RESMED INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2026
Q3 2025
Q3 2024
Q3 2023
Q3 2022
Q3 2021
Operating cash flow
$422.42M
$457.32M
$325.54M
$286.28M
$44.66M
-$65.66M
Capital expenditure
$48.74M
$42.97M
$17.84M
$30.04M
$29.06M
$27.34M
Investing cash flow
$392.06M
-$52.58M
$2.15M
-$148.98M
-$58.81M
-$41.87M
Dividends paid
$94.95M
$87.75M
$77.89M
$70.60M
RMD operating cash flow (10-K history)
RESMED INC reported operating cash flow of $1.81B for fiscal year 2026. That is up 3.1% from $1.75B in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $414.05M (FY 2017) to $1.81B. Figures come from the company's audited annual reports as filed with the SEC.
